← SynDRA
QUISINOSTAT
SynDRA canonical compound SYN0031622 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | MDM2 |
|---|
| Mechanism of action | HDAC inhibitor |
|---|
All known targets
- HDAC1
- HDAC10
- HDAC11
- HDAC2
- HDAC3
- HDAC4
- HDAC5
- HDAC6
- HDAC7
- HDAC8
- HDAC9
- MDM2
Mechanisms of action (all sources)
- histone deacetylase inhibitor
- HDAC1 INHIBITOR
- HDAC3 INHIBITOR
- HDAC6 INHIBITOR
- HDAC2 INHIBITOR
- HDAC5 INHIBITOR
- HDAC7 INHIBITOR
- HDAC8 INHIBITOR
- HDAC11 INHIBITOR
- HDAC4 INHIBITOR
- HDAC9 INHIBITOR
- HDAC10 INHIBITOR
Cross-references
Synonyms
- JNJ-26481585
- N-Hydroxy-2-(4-((((1-methyl-1H-indol-3-yl)methyl)amino)methyl)piperidin-1-yl)pyrimidine-5-carboxamide
- UNII-9BJ85K1J8S
- Quisinostat (JNJ-26481585)
- JNJ26481585
- 9BJ85K1J8S
- N-hydroxy-2-[4-[[(1-methylindol-3-yl)methylamino]methyl]piperidin-1-yl]pyrimidine-5-carboxamide
- 2-[4-[[(1-methylindol-3-yl)methylamino]methyl]piperidin-1-yl]-~{N}-oxidanyl-pyrimidine-5-carboxamide
- N-Hydroxy-2-(4-((((1-methyl-1H-indol-3-yl)methyl)amino)-methyl)piperidin-1-yl)pyrimidine-5-carboxamide
- JNJ-26854165
- JNJ 26481585
- quisinostatum
- RefChem:930503
- DTXCID90158867
- HDAC Inhibitor JNJ-26481585
- MFCD17010272
- Quisinostat HCl
- JNJ-26481585-d3
- Quisinostat [USAN]
- Quisinostat [USAN:INN]
- GOK
- QUISINOSTAT [INN]
- Quisinostat (USAN/INN)
- QUISINOSTAT [WHO-DD]
- MLS006011096
- GTPL7503
- orb1301114
- SCHEMBL2360460
- SCHEMBL29355421
- CHEBI:94771
- JNJ 26481585 dihydrochloride
- GLXC-03748
- HMS3654M19
- HMS3747E21
- AKB32029
- BDBM50105327
- NSC759657
- AKOS016004011
- CS-5065
Look up QUISINOSTAT in the interactive SynDRA portal →